Similar to the mutations reported for ARID1A, truncating mutations have also been identified for ARID1B although in a lesser frequency and most of them associated with neurodevelopmental disorders (Santen et al., 2012) or neuroblastomas (Lee et al., 2017). This evidence concerns the gene ARID1A and neuroblastoma.